Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes

Circulation Research

Volumn 81, Issue 6, 1997, Pages 911-921

  Kinugawa, Koh Ichiro ^a   Shimizu, Tatsuya ^a   Yao, Atsushi ^a   Kohmoto, Osami ^a   Serizawa, Takashi ^a   Takahashi, Toshiyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cardiac myocyte; Inducible nitric oxide synthase; Neonatal rat; Nuclear factor; Transcriptional regulation

Indexed keywords

FORSKOLIN; GAMMA INTERFERON; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; NUCLEAR FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL STIMULATION; COMPLEX FORMATION; DNA FLANKING REGION; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY; ENZYME INDUCTION; ENZYME SYNTHESIS; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0030734515     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.6.911     Document Type: Article

References (63)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
2. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363-380.
3. 2+] and cell contraction in cultured chick ventricular myocytes. Circ Res. 1994;75:285-295.
4. Kinugawa K, Kohmoto O, Yao A, Serizawa T, Takahashi T. Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes. Am J Physiol. 1997;272:H35-H47.
5. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93:1087-1094.
6. Lewis NP, Tsao PS, Rickenbacher PR, Xue C, Johns RA, Haywood GA, von der Leyen H, Trindade PT, Cooke JP, Hunt SA, Billingham MA, Valantine HA, Fowler MB. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation. 1996;93:720-729.
7. Satoh M, Tamura G, Segawa I, Tashiro A, Hiramori K, Satodate R. Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Arch. 1996;427:503-509.
8. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman MH. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Circulation. 1995;92:1866-1875.
9. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schomig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995;92:748-755.
10. Deng MC, Erren M, Kammerling L, Gunther F, Kerber S, Fahrenkamp A, Assmann G, Breithardt G, Scheld HH. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation. 1995;60:1118-1124.
11. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by Interferon γ and lipopolysaccharide. Proc Natl Acad Sci U S A. 1993;90:9730-9734.
12. Xie Q-W, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J Exp Med. 1993;177:1779-1784.
13. Martin E, Nathan C, Xie Q-W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med. 1994; 180:977-984.
14. Xie Q-W, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269:4705-4708.
15. Eberhardt W, Kunz D, Hummel R, Pfeilschifter J. Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem Biophys Res Commun. 1996;223:752-756.
16. Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, Billiar TB, Hutchinson NI, Mudgett JS. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem. 1994;269:6765-6772.
17. De Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL Jr, Morris MS, Billiar TR, Geller DA. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A. 1996;93:1054-1059.
18. Lin AW, Chang CC, McCormick CC. Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5′-flanking region. J Biol Chem. 1996; 271:11911-11919.
19. LaPointe MC, Sitkins JR. Mechanisms of interleukin-1beta regulation of nitric oxide synthesis in cardiac myocytes. Hypertension. 1996;27:709-714.
20. 2+ -growth coupling in angiotensin II-induced hypertrophy in cultured rat cardiac cells. Cariovasc Res. 1995;30:419-431.
21. Yao A, Takahashi T, Aoyagi T, Kinugawa K, Kohmoto O, Sugiura S, Serizawa T. Immediate-early gene induction and MAP kinase activation during recovery from metabolic inhibition in cultured cardiac myocytes. J Clin Invest. 1995;96:69-77.
22. Betts JC, Cheshire JK, Akira S, Kishimoto T, Woo P. The role of NF-κB and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression. J Biol Chem. 1993;268:25624-25631.
23. Fujita T, Shibuya H, Hotta H, Yamanishi K, Taniguchi T. Interferon-β gene regulation: tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer. Cell. 1987;49:357-367.
24. Singh K, Balligand J-L, Fischer TA, Smith TW, Kelly RA. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells: role of extracellular signal-regulated kinases (ERK1/ERK2) and STAT1α. J Biol Chem. 1996;271:1-7.
25. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito N, Toshioka T, Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem. 1990;265:4924-4927.
26. Hidaka H, Sasaki Y, Tanaka T, Endo T, Ohno S, Fujii Y, Nagala T. N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci U S A. 1981;78:4354-4357.
27. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibition of protein kinase C. Biochem Biophys Res Commun. 1989;159:548-553.
28. Toullec D, Pianetti P, Coste H. Bellevergue P, Grand-Perret T, Ajakane M, Baudot V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinasc C. J Biol Chem. 1991;266:15771-15781.
29. Kawamoto S, Hidaka H. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun. 1984;125:258-264.
30. Fallon J. Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes. Biochem Biophys Res Commun. 1990;170:1191-1196.
31. Pang L, Sawada T, Decker SJ, Saltiel AR. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem. 1995;270:13585-13588.
32. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. J Biol Chem. 1994;269:13289-13296.
33. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcriptional factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci U S A. 1994;91:752-756.
34. Schütze S, Muchleidt T, Krönke M. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leukoc Biol. 1994;56:533-541.
35. Akira S, Ishii H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima, Hirano T, Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990;9:1897-1906.
36. 2+ and cyclic AMP in addition to inhibiting protein kiriase C in rat islets of Langerhans. Mol Cell Endocrinol. 1993;94:55-60.
37. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 1994;263:1612-1615.
38. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T. Regulated expression of a gene encoding a nuclear factor. IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell. 1988;54:903-913.
39. Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T. Taniguchi T. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell. 1990;63:303-312.
40. Harroch S, Revel M, Chebath J. Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1 ) gene response element pIRE and cell type-dependent control of IRF-1 binding to DNA. EMBO J. 1994;13:1942-1949.
41. Goldring CEP, Reveneau S, Algarte M, Jeannin J-F. In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct. and NF-IL6. Nucleic Acids Res. 1996;24:1682-1687.
42. Oddis CV, Simmons RL, Hattler BG, Finkel MS. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol. 1995;269:H2044-H2050.
43. Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokoyama M. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. J Biol Chem. 1993;268:24959-24966.
44. Yamamoto KK, Gonzalez GA, Biggs WH III, Montminy MR. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature. 1988;334:494-498.
45. Nichols M, Weih F, Schmid W, DeVack C, Kowenz-Leutz E, Luckow B, Boshart M, Schütz G. Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription, EMBO J. 1992;11:3337-3346.
46. Goldspink PH, Russell B. The cAMP response element binding protein is expressed and phosphorylated in cardiac myocytes. Circ Res. 1994;74:1042-1049.
47. Vallejo M, Ron D, Miller CP, Habener JF. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc Natl Acad Sci U S A. 1993;90:4679-4683.
48. Tsukada J, Saito K, Waterman WR, Webb AC, Auron PE. Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1β gene. Mol Cell Biol. 1994;14:7285-7297.
49. Fujihara M, Muroi M, Muroi Y, Ito N. Suzuki T. Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). J Biol Chem. 1993;268:14898-14905.
50. Meyer TE, Waeber G, Lin J, Beckmann W, Habener JF. The promoter of the gene encoding 3′, 5′-cyclic adenosine monophosphale (cAMP) response element binding protein contains cAMP response elements: evidence for positive autoregulation of gene transcription. Endocrinology. 1993;132:779-780.
51. Ginty DD, Bonni A, Greenberg ME. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell. 1994;77:713-725.
52. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S. Phosphorylation at threonine-235 by a rasdependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A. 1993;90:2207-2211.
53. Weinstein SL, Sanghera JS, Lemke K, DeFranco AL, Peleeh SL. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J Biol Chem. 1992;267:14955-14962.
54. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808-811.
55. Daeipour M, Kumar G, Amarel MC, Nel AE. Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10. J Immunol. 1994;150:4743-4753.
56. Van Lint J, Agostinis P, Vandevoorde V, Haegeman G, Fiers W, Merlevede W, Vandenheede JR. Tumor necrosis factor stimulates multiple serine/threonine protein kinases in Swiss 3T3 and L929 cells: implication of casein kinase-2 and extracellular signal-regulated kinases in the tumor necrosis factor signal transduction pathways. J Biol Chem. 1992;267:25916-25921.
57. Schreck R, Meier B, Männel DN, Dröge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med. 1992;175:1181-1194.
58. Ishikawa Y, Mukaida N, Kuno K, Rice N, Okamoto S, Matsushima K. Establishment of lipopolysaccharide-dependent nuclear factor κB activation in a cell-free system. J Biol Chem. 1995;270:4158-4164.
59. Darnell JE Jr, Kerr IE, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415-1421.
60. Zhang X. Blenis J, Li H-C, Schindler C, Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science. 1995;267:1990-1994.
61. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996;84:431-442.
62. Khemlani LS, Yang Z, Bochsler PN. Identification and characterization of a bovine lipopolysaccharide-binding protein. J Leukoc Biol. 1994;56:784-791.
63. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon JA, Tandon PK, DeMets DL. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325:1468-1475.